Formed in 2003, BlueGnome, a specialist developer of microarray based solutions for the screening of chromosomal abnormalities in cytogenetics and IVF, has been ranked fasted growing Biotechnology company by The Deliotte Technology Fast 50.
Impressively, the Biotech company has been ranked the 25th fastest growing company in the UK across all sectors. CEO of BlueGnome, Nick Haan, stated, ‘This award recognises BlueGnome’s ability to evolve as technologies for the investigation of genetic disease develop. We have a fantastic team at BlueGnome here in Cambridge and our office in the United States which enable us to achieve this level of sales growth, while also remaining profitable, even through times of recession and cut backs.’
Graham Snudden, VP Engineering, added ‘We pride ourselves on excellent customer service combined with the latest technology to allow our customers to improve the quality of their genetic services. Recent growth is mostly attributable to our 24sure technology which makes aneuploidy screening of single cells possible.’
The Fast 50 ranking reflects the fastest growing technology companies in the UK based on percentage growth in revenues over five years. The growth of BlueGnome highlights the biotech company’s new staff hires and increased productivity at their Cambridge headquarters.
BlueGnome is a supplier of diagnostic products; microarrays, consumables, software, for molecular cytogenetics. They are a leader in in the provision of genetics tests and software for diagnosis of genetic disorders and improving fertility in IVF. To find out more, visit their website.
Are you looking for a job in the Biotechnology Industry? Click here to search our current biotechnology jobs online now.
As reported by Chemical and Engineering News, the leading Biotechnology company, Amgen and biopharmaceutical company, Celgene are making steps to strengthen their oncology drug pipelines through acquisitions.
